logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12734180 B1

PDFFull Text
Date of Patent:
Sep. 15, 2026

Filed:

May. 07, 2021

Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone

Applicant:

Janssen Pharmaceutica NV, Beerse, BE;

Inventors:

Thomas Ronald A. Quinten, Zeveneken, BE;

Urbain Alfons C. Delaet, Balen, BE;

Philip Erna H. Heyns, Vosselaar, BE;

Tatiana Marcozzi, Borgerhout, BE;

Johny Bertels, Mol, BE;

Katrien Luyten, Oud-Turnhout, BE;

Kaustubh Ramesh Tambwekar, Geel, BE;

Angela Lopez-Gitlitz, Los Angeles, CA (US);

Paul J. A. Hartman Kok, Eersel, NL;

Assignee:

Janssen Pharmaceutica NV, Beerse, BE;

Attorney:

BakerHostetler

Primary Examiner:

Elly-Gerald Stoica

Int. Cl.
CPC ...
A61K 31/58 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 31/454 (2006.01); A61K 31/573 (2006.01); A61K 38/25 (2006.01); A61P 13/08 (2006.01); A61P 15/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/58 (2013.01); A61K 9/1617 (2013.01); A61K 9/1635 (2013.01); A61K 9/1694 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/28 (2013.01); A61K 31/454 (2013.01); A61K 31/573 (2013.01); A61K 38/25 (2013.01); A61P 13/08 (2018.01); A61P 15/00 (2018.01); A61P 35/00 (2018.01); A61P 35/04 (2018.01);
Abstract

The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations.

Find Patent Forward Citations

Quick Actions:

Quinten, Thomas Ronald A.. (2026). Treatment of prostate cancer with a combination of abiraterone acetate, niraparib tosylate monohydrate and prednisone (U.S. Patent No. 12734180). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12734180

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…